The White House today announced landmark drug pricing agreements with Eli Lilly and Company and Novo Nordisk to lower the ...

Panelists discuss how accurate and early diagnosis remains one of the most difficult challenges in schizophrenia care. Many ...

Panelists discuss how genetic predisposition is a major determinant in schizophrenia risk, with heritability playing a ...

Panelists discuss how pharmacy-driven barriers, including delayed statin initiation and failure to escalate therapy, ...

Chronic urticaria affects 17% of patients, with higher age, elevated BMI, and early prednisolone use as key determinants of prolonged disease duration. The study utilized data from the Julius General ...

CMS introduced the GENEROUS Model to reduce Medicaid drug costs, enhance access, and improve health outcomes for ...

A new option is now approved to treat adults living with high-risk smoldering multiple myeloma. 1 The FDA has greenlit ...

A national survey found 13.1% of US youths use generative AI for mental health advice, with higher usage among those aged 18 to 21. Most users found AI advice helpful, but Black respondents were less ...

These 3 studies, to be presented at the American Heart Association (AHA) Scientific Sessions 2025, explored how these interventions can help reduce cardiovascular and cognitive risks in adults with ...

Syndromic real-time PCR tests for respiratory infections provide economic advantages by improving healthcare utilization and reducing costs.

Medicare Advantage plans that place greater restrictions on home health agency care delivery may have more adverse patient outcomes than plans that provide episodic payments.

In late September, oncology experts gathered in Nashville, Tennessee, for the 2025 Patient-Centered Oncology Care ® conference. Over 2 days, 15 panel discussions explored topics aligned with this year ...